MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$11.48 -0.32 (-2.71%)
Open Price: 11.66
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients